This report analysed data from the Health Survey for England 1994 to evaluate blood pressure (BP) management in relation to cigarette smoking. Data were analysed for 12 013 adults aged у16 years living in England in 1994. Among 2280 subjects with BP у160/95 mm Hg or treated with BP-lowering medication, rates of awareness were 63% in never-smokers, 66% in ex-smokers and 51% in current smokers. After adjusting for age, sex, housing tenure, educational attainment, and systolic and diastolic BP, the relative odds of hypertension awareness for smokers, compared with never-smokers, were 0.63, 95% confidence interval 0.49 to 0.82,
Introduction
Cigarette smoking is an important risk factor for cardiovascular disease which contributes to inequalities in health because of an association with lower socioeconomic status. 1 Cigarette smoking appears to have little direct effect on blood pressure (BP) 2 but there is strong evidence that lower socioeconomic status is associated with higher BP. 3 Groups with lower socioeconomic status are at risk because they are exposed to an increased prevalence of both hypertension and cigarette smoking, together with the synergistic effect of these two risk factors. 2 Clinical guidelines on the diagnosis and management of high BP suggest that efforts to detect and treat high BP should be especially intense in subjects who smoke or have other risk factors for cardiovascular disease. 4 This paper reports an analysis of data from the Health Survey for England 1994 which tested the hypothesis that diagnosis and treatment of high BP would be less frequent in those who smoked. P Ͻ 0.001. In the same group, the rates of BP treatment were 50% in never-smokers, 53% in ex-smokers and 36% in current smokers (odds ratio 0.64, 0.49 to 0.84, P = 0.001). In 4500 subjects with BP у140/90 mm Hg or treated, there was also strong evidence that current smokers were less likely to be aware of their high BP or treated. In this group, ex-smokers were more likely than never-smokers to be aware (odds ratio 1. 
Methods
Data from the Health Survey for England 1994 were provided by the Data Archive, University of Essex. The data are Crown Copyright and were used by permission of the Office for National Statistics. The data were obtained from a survey of a representative sample of adults aged 16 years and over living in England in 1994. The sampling design and data collection procedures have been reported in detail by Colhoun and Prescott-Clarke. 5 Post-code sectors were the primary sampling unit and households were sampled within post-code sectors. A questionnaire was administered by interview which included details of cigarette smoking and BP treatment. 5, 6 BP was measured using a Dinamap 8100 device. Finally, details of any medication prescribed to the subject were noted by the interviewer. The following variables were included in this analysis: diastolic BP (mm Hg), systolic BP (mm Hg); cigarette smoking (never, ex-smoker, current); whether subjects reported that they had been told that they had high BP by a doctor or nurse (except when pregnant); whether they were currently taking prescribed medication that lowered BP; whether they had received medical advice to stop smoking; and whether they had tried to give up smoking because Journal of Human Hypertension of a medical condition. Housing tenure and educational attainment were used as indicators of socioeconomic status. We followed the approach to analysis taken by Colhoun and colleagues. 6 Two definitions of hypertension were used: (i) BP у160/95 mm Hg or treated for hypertension, and (ii) BP у140/90 mm Hg or treated for hypertension. Logistic regression analyses were performed using robust variance estimates to allow for clustering of responses by household. 7 Odds ratios were adjusted for sex, housing tenure and educational attainment and continuous variables, age, diastolic BP and systolic BP. P values were obtained by comparing the coefficient with its standard error in the logistic regression model.
Results
There were 15 809 subjects in the survey. Cases were omitted if they had missing values for BP (2483), BP medication (773), cigarette smoking (27), age (1), or if they were taking prescribed medication affecting BP but had no history of a diagnosis of hypertension or its treatment (512). There were then 12 013 (76%) cases remaining for further analysis. (Colhoun et al 6 included 12 116 cases). The aggregated results and statistical analyses are shown in Table 1 .
Among those with BP у160/95 mm Hg or treated, there was strong evidence that current smokers had less often been given a diagnosis of high BP, and were less likely to be treated with BP-lowering medication, than those who had never smoked. There was weak evidence that ex-smokers tended more often to have been given a diagnosis of high BP and tended to be more likely to be taking BPlowering medication. The analysis was repeated among those who were hypertensive according to the second definition. Here again, there was strong evidence that smokers were less likely to be aware of their hypertension or to be treated for hypertension. In this group, there was strong evidence that ex-smokers were more likely to be aware of their high BP or to be treated. Rates of BP control were higher in ex-smokers but similar in current smokers and those who had never smoked. This appeared to result from the differing treatment rates, when control rates were expressed as a proportion of those treated for hypertension there was little variation according to smoking status. More current smokers had received medical advice to stop smoking than ex-smokers, but slightly more ex-smokers had tried to give up smoking because of a medical condition.
Discussion
At a given level of BP and socioeconomic status, people who currently smoke were less likely either to be diagnosed with high BP, or to be treated with medication, than those who never smoked. These data were collected in 1994 when recommendations to implement BP management according to the level of cardiovascular risk were already well established 4 and it might have been expected that higher rates of detection and treatment would have been achieved in smokers.
A tendency for smokers to give up the habit after a diagnosis of hypertension is made might partly explain why diagnosis and treatment might be less frequent in smokers but more frequent in ex-smokers. The data might be interpreted as showing the success of smoking cessation advice in those with high BP. The finding that fewer ex-smokers, than current smokers, had received medical advice to stop smoking is not consistent with this suggestion. However, there may be some bias in the recall of smoking cessation advice between smokers and exsmokers.
Much of the reported difference in treatment rates between smokers and non-smokers was explained by a difference in the rate of awareness of hypertension. This differential ascertainment might be partly explained by lower uptake of opportunities for preventive health care among smokers. 8 The findings reported here also raise questions about the quality of BP management by health professionals in people who continue to smoke. BP management is known to be unsatisfactory in all groups in England 4 but the present report identifies current smokers as a group in whom intensified efforts to identify and treat high BP will be particularly relevant.
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